Enterobacter cloacae infection of an expanded polytetrafluoroethylene femoral-popliteal bypass graft: a case report.
BACKGROUND
Enterobacter cloacae infections are common among burn victims, immunocompromised patients, and patients with malignancy. Most commonly these infections are manifested as nosocomial urinary tract or pulmonary infections. Nosocomial outbreaks have also been associated with colonization of certain surgical equipment and operative cleaning solutions. Infections of an aortobifemoral prosthesis, an aortic graft, and arteriovenous fistulae are noted in the literature. To our knowledge, this is the first isolated account of an E. cloacae infection of a femoral-popliteal expanded polytetrafluoroethylene bypass graft.


METHODS
A 68-year-old Caucasian man presented with fever and rest pain in the right lower extremity five months after the placement of a vascular expanded polytetrafluoroethylene graft for femoral-popliteal bypass. Computed tomography angiography demonstrated peri-graft fluid that was aspirated percutaneously with image guidance and cultured to reveal E. cloacae. The graft was revised and then removed. The patient completed a six-week course of ceftazidime and is currently without signs of infection. There were no other reports of E. cloacae graft infections in any patients receiving treatment in the same surgical suite within a month of this report.


CONCLUSIONS
Isolated cases of E. cloacae infection of surgical bypass grafts are rare (unique in this setting). Clinicians should have a high index of suspicion for device contamination in such cases and should consider testing for possible microbial reservoirs. Graft removal is required due to the formation of biofilm and the recent emergence of Enterobacteriaceae producing extended-spectrum beta-lactamase in community acquired infections.
Musil
Ian
I
Tucson Hospitals Medical Education Program, 1501 N, Campbell Avenue, PO Box 245066, Tucson, Arizona 85724-5066, USA. Sue.Corcoran@tmcaz.com.
Jensen
Vanessa
V
Schilling
Jolyon
J
Ashdown
Boyd
B
Kent
Tyler
T
Scand J Infect Dis. 1989;21(2):181-91
2727635
An Med Interna. 2002 May;19(5):246-50
12108001
J Antimicrob Chemother. 2005 Dec;56(6):996-9
16269550
N Engl J Med. 1989 Oct 5;321(14):935-40
2779615
Nefrologia. 2003 Jul-Aug;23(4):333-43
14558333
Am J Infect Control. 1994 Aug;22(4):195-201
7985817
Mol Biosyst. 2005 Sep;1(3):196-202
16880983
J Am Soc Nephrol. 1998 Jul;9(7):1314-7
9644644
J Infect. 2006 Jul;53(1):49-55
16310254
Surg Gynecol Obstet. 1988 Apr;166(4):295-301
3127896
J Thorac Cardiovasc Surg. 1986 Feb;91(2):296-302
3753734
J Antimicrob Chemother. 2005 Jul;56(1):52-9
15917288
Am J Surg. 1973 Dec;126(6):798-802
4758802
J Vasc Interv Radiol. 2009 Feb;20(2):173-9
19097807
Ann Vasc Surg. 1992 Nov;6(6):517-24
1463665
Surg Gynecol Obstet. 1974 Sep;139(3):446-52
4277536
Chest. 1978 Nov;74(5):508-13
738087
J Vasc Surg. 2001 May;33(5):948-54
11331833